Show simple item record

dc.contributor.authorAtiomo, William
dc.date.accessioned2023-01-26T04:55:46Z
dc.date.available2023-01-26T04:55:46Z
dc.date.issued2022
dc.identifier.issn204-2022.34
dc.identifier.urihttps://repository.mbru.ac.ae/handle/1/1045
dc.description.abstractAbstract: Pre-eclampsia is the most common pregnancy complication affecting 1 in 20 pregnancies, characterized by high blood pressure and signs of organ damage, most often to the liver and kidneys. Metabolic network analysis of published lipidomic data points to a shortage of Coenzyme A (CoA). Gene expression profile data reveal alterations to many areas of metabolism and, crucially, to conflicting cellular regulatory mechanisms arising from the overproduction of signalling lipids driven by CoA limitation. Adverse feedback loops appear, forming sphingosine-1-phosphate (a cause of hypertension, hypoxia and inflammation), cytotoxic isoketovaleric acid (inducing acidosis and organ damage) and a thrombogenic lysophosphatidyl serine. These also induce mitochondrial and oxidative stress, leading to untimely apoptosis, which is possibly the cause of CoA restriction. This work provides a molecular basis for the signs of pre-eclampsia, why polycystic ovary syndrome is a risk factor and what might be done to treat and reduce the risk of disease.en_US
dc.language.isoenen_US
dc.subjectpre-eclampsiaen_US
dc.subjectPolycystic ovary syndromeen_US
dc.subjectAdverse antenatal conditionsen_US
dc.subjectCoenzyme Aen_US
dc.subjectMetabolomicsen_US
dc.subjectTranscriptomicsen_US
dc.subjectGenome-wide association studyen_US
dc.subjectPlacentaen_US
dc.subjectPhysiological dysregulationen_US
dc.subjectSystems pathologyen_US
dc.titleCoenzyme A Restriction as a Factor Underlying Pre-Eclampsia with Polycystic Ovary Syndrome as a Risk Factoren_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record